Previous close | 220.99 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 7,518 |
Market cap | 630.414M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 0.58 |
EPS (TTM) | 3.84 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Revvity's (RVTY) first-quarter results showcase a decline in life sciences segmental revenues. However, the company's earnings and revenues beat their respective estimates.
U. S. Silica's (SLCA) earnings and sales miss estimates in the first quarter amid lower sales volumes in Oil & Gas.
Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.